PXL/HO/Cir-149/2025-26                                                                 Date: 19-03-2026

Hyderabad

Subject: URGENT – Immediate Inputs Required on Impact of West Asia Situation on Pharma Sector

Dear Sir / Madam,

Greetings from PHARMEXCIL.

In view of the evolving geopolitical situation in West Asia, which is significantly impacting global trade routes, energy supply chains, logistics costs, and availability of key inputs, it is imperative to urgently assess the impact on India’s pharmaceutical sector, particularly in terms of exports, production costs, and supply chain continuity.

In this regard, PHARMEXCIL is compiling critical inputs from member companies to prepare a comprehensive and time-sensitive representation to the Government of India, for seeking appropriate policy support, relief measures, and facilitative interventions.

Google Form Link: West Asia Impact Assessment

Deadline for submission: March 20,2026 by 12 noon

The format includes critical sections to capture quantitative data on cost escalation, export losses, and operational impact (before vs current scenario), which will be instrumental in strengthening the industry’s case.

This exercise is extremely critical and time-sensitive. The inputs received will directly support PHARMEXCIL’s representation at the highest levels of Government to seek urgent relief measures and policy intervention for the pharmaceutical sector.

We request your immediate attention and prompt response.

With warm regards,

Raja Bhanu K
Director General